A new drug to treat attention deficit hyperactivity disorder
(ADHD) has been cautiously welcomed by children’s mental
health charity YoungMinds.
According to its manufacturer, atomoxetine can provide 24 hour
relief from the symptoms of ADHD in children and adolescents.
Dinah Morley, acting director of YoungMinds, said that it is
always “useful” to have a new option available, as not
every child responds to Ritalin which is often prescribed for
“However, medication should not be seen as a substitute
for talking therapies which can address the root causes of mental
health problems. Nevertheless, drug treatments are useful for many
families as part of a coherent package of care,” she
The drug’s brand name is Strattera, and it is manufactured
by pharmaceutical company Eli Lilly.